Skip to main content
Log in

Topical 5-fluorouracil first choice for treatment of actinic keratosis

  • Clinical study
  • Published:
PharmacoEconomics & Outcomes News

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Reference

  • Jansen MHE, et al. A trial-based cost-effectiveness analysis of topical 5-fluorouracil vs imiquimod vs ingenol mebutate vs methylaminolevulinate conventional photodynamic therapy for the treatment of actinic keratosis in the head and neck area performed in the Netherlands. British Journal of Dermatology : 21 Jan 2020. Available from: URL: http://doi.org/10.1111/bjd.18884

Download references

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Topical 5-fluorouracil first choice for treatment of actinic keratosis. PharmacoEcon Outcomes News 846, 28 (2020). https://doi.org/10.1007/s40274-020-6567-1

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40274-020-6567-1

Navigation